2024-12-25 Siyi Intelligence (Syrebo) HaiPress
SHANGHAI,Dec. 24,2024 -- Syrebo,a global leader in rehabilitation robotics,is proud to announce that its Hand Rehabilitation Robot has been granted official certification by the Therapeutic Goods Administration (TGA),marking a significant achievement in the company's mission to advance medical rehabilitation technology.

The Syrebo Hand Rehabilitation Robot is a cutting-edge,robotic-assisted device designed to facilitate the rehabilitation of patients recovering from neurological conditions,hand injuries,or stroke-related impairments. Combined with soft robotic exoskeleton technology and neuroscience,it integrates a variety of training methods,such as passive training,mirror training,active training,etc.,providing patients with effective and convenient solutions to recover hand function.
Achieving TGA certification represents a pivotal milestone for Syrebo and is a testament to the safety,efficacy,and quality of the Hand Rehabilitation Robot. The certification will allow Syrebo to expand its reach in Australia and provide therapists with a innovative tool for enhancing patient care and rehabilitation outcomes. "With Syrebo's successful penetration into the European and U.S. markets,the new TGA certification will further expand our global presence," said Gavin Yin,Founder & CEO of Syrebo. Syrebo plans to collaborate closely with healthcare institutions and rehabilitation centers across Asia-Pacific to integrate their rehabilitation solutions into therapeutic programs.

Syrebo lnnovative Rehabilitation Solutions for Hospitals/Communities/Families
Visit SYREBO on social media:
Facebook: http://www.facebook.com/syrebosiyiintelligence/
LinkedIn: http://www.linkedin.com/company/syrebo
Youtube: http://www.youtube.com/@syrebo
More about SYREBO,please check on the following link
http://www.syrebo.com
info@syrebo.com
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map